Quick Answer
Baird Medical Investment Holdings Ltd reported Total Revenue of $37.04 million for fiscal year 2024.
Baird Medical Investment Holdings Ltd — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | $37.04M +17.7% |
$31.46M -10.4% |
$35.09M | — |
| Revenue (ASC 606) | $37.04M +17.7% |
$31.46M -10.4% |
$35.09M | — |
| Diluted EPS | $0.49 +19.5% |
$0.41 -16.3% |
$0.49 | — |
| Total Assets | $77.96M +37.5% |
$56.71M | — | — |
| Long-Term Debt | $3.44M +113.3% |
$1.61M | — | — |
| Stockholders Equity | $39.66M +10.9% |
$35.75M +38.7% |
$25.78M +77.7% |
$14.51M |
| R&D Expense | $6.17M +44.4% |
$4.27M +10.8% |
$3.86M | — |
| Operating Income | $15.32M +29.1% |
$11.86M -13.0% |
$13.63M | — |
| Gross Profit | $32.65M +19.9% |
$27.23M -2.9% |
$28.04M | — |
- Baird Medical Investment Holdings Ltd reported Total Revenue of $37.04 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +17.7% in Total Revenue compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Revenue (ASC 606) of $37.04 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +17.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Diluted EPS of $0.49 per share for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +19.5% in Diluted EPS compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Total Assets of $77.96 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +37.5% in Total Assets compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Long-Term Debt of $3.44 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +113.3% in Long-Term Debt compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Stockholders Equity of $39.66 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +10.9% in Stockholders Equity compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported R&D Expense of $6.17 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +44.4% in R&D Expense compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Operating Income of $15.32 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +29.1% in Operating Income compared to the prior fiscal year.
- Baird Medical Investment Holdings Ltd reported Gross Profit of $32.65 million for fiscal year 2024.
- Baird Medical Investment Holdings Ltd showed an increase of +19.9% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: